IM Cannabis Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 26/31 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 0.00.In the medium term, the stock price is expected to trend down.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IM Cannabis Corp's Score
Industry at a Glance
Industry Ranking
26 / 31
Overall Ranking
429 / 4582
Industry
Food & Drug Retailing
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
IM Cannabis Corp Highlights
StrengthsRisks
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Growing
The company is in a growing phase, with the latest annual income totaling USD 37.56M.
Undervalued
The company’s latest PE is -1.81, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 240.32K shares, decreasing 8.53% quarter-over-quarter.
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Ticker SymbolIMCC
CompanyIM Cannabis Corp
CEOFisher (Eyal)
Websitehttps://imcannabis.com/
FAQs
What is the current price of IM Cannabis Corp (IMCC)?
The current price of IM Cannabis Corp (IMCC) is 1.560.
What is the symbol of IM Cannabis Corp?
The ticker symbol of IM Cannabis Corp is IMCC.
What is the 52-week high of IM Cannabis Corp?
The 52-week high of IM Cannabis Corp is 7.120.
What is the 52-week low of IM Cannabis Corp?
The 52-week low of IM Cannabis Corp is 0.930.
What is the market capitalization of IM Cannabis Corp?
The market capitalization of IM Cannabis Corp is 8.19M.
What is the net income of IM Cannabis Corp?
The net income of IM Cannabis Corp is -10.59M.
Is IM Cannabis Corp (IMCC) currently rated as Buy, Hold, or Sell?
According to analysts, IM Cannabis Corp (IMCC) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of IM Cannabis Corp (IMCC)?
The Earnings Per Share (EPS TTM) of IM Cannabis Corp (IMCC) is -0.863.